🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Serum Collection Study for Assay Development

RecruitingPhase 1Ages 18 Years - 69 YearsAllGPN Vaccines
NCT07205289 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study will collect serum from 12 participants vaccinated with Gamma-PN to assist with assay development and validation

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * good general health Exclusion Criteria: * no previous pneumococcal vaccine
💊

What it tests

  • Gamma-PN
📍

Where

1 site
University of Adelaide Clinical Research Facility
Adelaide, Australia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy